Skip to main content
. 2022 Apr 22;44(5):1838–1850. doi: 10.3390/cimb44050126

Table 1.

Parameters evaluated in platelet concentrates.

Parameters Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
* Quality control
Swirling Positive Positive Positive Positive Positive Negative Negative
PC volume 3 mL 3 mL 3 mL 3 mL 3 mL 3 mL 3 mL
Leukocyte count
(108/70 mL)
0.51 ± 0.02 0.48 ± 0.02 0.42 ± 0.03 0.34 ± 0.03 0.25 ± 0.04 * 0.18 ± 0.06 * 0.12 ± 0.06 *
Platelet count (1010) 7.3 ± 0.10 6.9 ± 0.11 6.7 ± 0.15 6.4 ± 0.18 6.1 ± 0.21 5.8 ± 0.24 5.5 ± 0.30
pH 7.2 ± 0.02 7.2 ± 0.03 7.2 ± 0.01 7.3 ± 0.01 7.3 ± 0.02 7.3 ± 0.01 7.4 ± 0.05
miRNAs expression **
miR-127 0.30 ± 0.12 0.41 ± 0.16 0.43 ± 0.19 0.32 ± 0.17 0.24 ± 0.23 0.29 ± 0.21 0.35 ± 0.25
miR-320a 0.19 ± 0.11 0.27 ± 0.13 0.37 ± 0.13 * 0.53 ± 0.18 * 0.54 ± 0.19 * 0.56 ± 0.22 * 0.62 ± 0.22 *
Membrane proteins’ expression +
P2Y12 39.57 ± 2.14 39.48 ± 1.73 40.56 ± 1.97 41.64 ± 1.56 41.19 ± 1.28 42.87 ± 1.80 42.69 ± 1.32
CD62P 11.45 ± 3.12 13.76 ± 4.61 18.96 ± 5.22 21.70 ± 6.22 * 33.76 ± 6.25 * 38.26 ± 7.11 * 40.20 ± 7.17 *
CD41 94.32 ± 4.20 89.81 ± 2.81 87.54 ± 2.52 85.73 ± 1.98 80.11 ± 2.53 * 78.81 ± 3.22 * 75.54 ± 2.60 *
CD61 87.62 ± 3.43 83.51 ± 3.72 80.31 ± 3.53 78.13 ± 2.46 77.14 ± 3.25 * 75.21 ± 3.27 * 73.11 ± 4.10 *

Values are expressed as means ± standard deviations. * Gravimetric measurement. ** Values referring to the relative quantification of miRNAs mir127 mir320a, for mir-191. + Percentage of platelets positive for CD62P and for GPIIb and -IIIa. For the P2Y12 receptor, the mean fluorescence intensity (MFI) was evaluated.